Title: Clinical Trials in Recurrent Ovarian Cancer
Authors: Friedlander, Michael ×
Trimble, Edward
Tinker, Anna
Alberts, David
Avall-Lundqvist, Elisabeth
Brady, Mark
Harter, Philipp
Pignata, Sandro
Pujade-Lauraine, Eric
Sehouli, Jalid
Vergote, Ignace
Beale, Philip
Bekkers, Rudd
Calvert, Paula
Copeland, Lawrence
Glasspool, Ros
Gonzalez-Martin, Antonio
Katsaros, Dionysis
Kim, Jae Won
Miller, Brigitte
Provencher, Diane
Rubinstein, Lawrence
Atri, Mostafa
Zeimet, Alain
Bacon, Monica
Kitchener, Henry
Stuart, Gavin C E
on behalf of the Gynecologic Cancer InterGroup #
Issue Date: May-2011
Publisher: Blackwell Scientific Publications
Series Title: International Journal of Gynecological Cancer vol:21 issue:4 pages:771-775
Abstract: The 4th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup was held in Vancouver, Canada, in June 2010. Representatives of 23 cooperative research groups studying gynecologic cancers gathered to establish international consensus on issues critical to the conduct of large randomized trials. Group C, 1 of the 3 discussion groups, examined recurrent ovarian cancer, and we report the consensus reached regarding 4 questions. These included the following: (1) What is the role of cytoreductive surgery for recurrent ovarian cancer? (2) How do we define distinct patient populations in need of specific therapeutic approaches? (3) Should end points for trials with recurrent disease vary from those of first-line trials? (4) Is CA-125 progression alone sufficient for entry/eligibility into clinical trials?
ISSN: 1048-891X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science